Clinical Trials Logo

Clinical Trial Summary

A study to evaluate the pharmacokinetics and safety of TRK-100STP in Japanese, Chinese, and South Korean non-elderly healthy adult males.


Clinical Trial Description

n/a


Study Design

Allocation: Non-Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Single Group Assignment, Masking: Open Label


Related Conditions & MeSH terms


NCT number NCT01423435
Study type Interventional
Source Astellas Pharma Inc
Contact
Status Completed
Phase Phase 1
Start date August 2011
Completion date September 2011

See also
  Status Clinical Trial Phase
Completed NCT02875080 - Evaluation Study of the Bioavailability of Brexpiprazole Orally Disintegrating Tablets in Healthy Male Subjects Phase 1
Completed NCT04182958 - A Phase I, Open-Label Trial to Assess the Absorption, Metabolism, and Excretion of (14C)-OPC-61815 in Healthy Male Japanese Subjects Phase 1
Completed NCT03902574 - Bioequivalence Study of Brexpiprazole Orally Disintegrating Tablets (ODT) 2mg Phase 1
Completed NCT05439148 - OPC-61815 in Healthy Chinese Male Subjects Phase 1
Completed NCT02994394 - A Study of OPC-41061 Orally Disintegrating (OD) Tablets Using 2 Different Formulations and 2 Dosing Regimens in Healthy Adult Male Subjects Phase 1
Completed NCT04415645 - Absorption, Metabolism, Excretion, and Mass Balance Study of [14C]-VVZ-149 in Healthy Adult Male Subjects Phase 1
Completed NCT01258699 - A Study Comparing the Pharmacokinetics of BK-C-0701 320mg, 480mg and Thiocacid HR Tab 600mg in Healthy Adult Male Subjects Phase 1